GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

UHT · Sep 30, 2024

UNIVERSAL HEALTH REALTY INCOME TRUST. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000950170-24-124121Reit
Operating-cash-flow growth56thOwn-history percentile · N=9
Evidence method

Yoy · gp.fundamentals.operating_cash_flow

-2.65% · OPTIONAL · VALID

Net-income growth78thOwn-history percentile · N=9
Evidence method

Yoy · gp.fundamentals.net_income

3.23% · CORE · VALID

Revenue growth0thOwn-history percentile · N=9
Evidence method

Yoy · gp.fundamentals.revenue

1.12% · CORE · VALID

Cash and equivalents8thOwn-history percentile · N=13
Evidence method

Level · gp.fundamentals.cash

$6.4M · CORE · VALID

Operating-income growth56thOwn-history percentile · N=9
Evidence method

Yoy · gp.fundamentals.operating_income

5.79% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History17 statesSelf-history eligible
Period transition

What moved in the state?

Cash Generation Decreased
Previous
-1.04%
Current
-2.65%
Delta
-1.61%
Earnings Growth Decreased
Previous
51.78%
Current
3.23%
Delta
-48.56%
Growth Decreased
Previous
3.90%
Current
1.12%
Delta
-2.78%
Liquidity Increased
Previous
$5.6M
Current
$6.4M
Delta
$795,000
Profitability Decreased
Previous
29.79%
Current
5.79%
Delta
-24.00%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.